1. Home
  2. HNNA vs ONCY Comparison

HNNA vs ONCY Comparison

Compare HNNA & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HNNA
  • ONCY
  • Stock Information
  • Founded
  • HNNA 1989
  • ONCY 1998
  • Country
  • HNNA United States
  • ONCY Canada
  • Employees
  • HNNA N/A
  • ONCY N/A
  • Industry
  • HNNA Investment Managers
  • ONCY Pharmaceuticals and Biotechnology
  • Sector
  • HNNA Finance
  • ONCY Health Care
  • Exchange
  • HNNA Nasdaq
  • ONCY Nasdaq
  • Market Cap
  • HNNA 87.1M
  • ONCY 89.7M
  • IPO Year
  • HNNA N/A
  • ONCY 1999
  • Fundamental
  • Price
  • HNNA $11.54
  • ONCY $1.35
  • Analyst Decision
  • HNNA
  • ONCY Strong Buy
  • Analyst Count
  • HNNA 0
  • ONCY 5
  • Target Price
  • HNNA N/A
  • ONCY $5.00
  • AVG Volume (30 Days)
  • HNNA 9.1K
  • ONCY 1.2M
  • Earning Date
  • HNNA 08-06-2025
  • ONCY 11-11-2025
  • Dividend Yield
  • HNNA 4.63%
  • ONCY N/A
  • EPS Growth
  • HNNA 56.56
  • ONCY N/A
  • EPS
  • HNNA 1.25
  • ONCY N/A
  • Revenue
  • HNNA $35,816,000.00
  • ONCY N/A
  • Revenue This Year
  • HNNA N/A
  • ONCY N/A
  • Revenue Next Year
  • HNNA N/A
  • ONCY N/A
  • P/E Ratio
  • HNNA $9.38
  • ONCY N/A
  • Revenue Growth
  • HNNA 32.04
  • ONCY N/A
  • 52 Week Low
  • HNNA $8.43
  • ONCY $0.33
  • 52 Week High
  • HNNA $13.88
  • ONCY $1.53
  • Technical
  • Relative Strength Index (RSI)
  • HNNA 45.74
  • ONCY 64.00
  • Support Level
  • HNNA $11.36
  • ONCY $1.20
  • Resistance Level
  • HNNA $12.30
  • ONCY $1.44
  • Average True Range (ATR)
  • HNNA 0.58
  • ONCY 0.11
  • MACD
  • HNNA -0.01
  • ONCY 0.01
  • Stochastic Oscillator
  • HNNA 10.98
  • ONCY 79.07

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: